Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine
Miltenyi Biotec

Where: D6/D7
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

Presentations at Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Staff Attending

Dr Kevin Chalmers
Senior Account Manager
Miltenyi Biotec
Dr Charlotte Egan
Application Specialist Manager
Miltenyi Biotec
Dr Dawn Farrar
UK Marketing Manager
Miltenyi Biotec Ltd
Mr Andrew Hill
Imaging Specialist
Miltenyi Biotec
Ben Morgan
Technical Sales Consultant
Miltenyi Biotec Ltd
Dr Graeme Pollock
Instrument Specialist
Miltenyi Biotec
Dr Elly Rankin
Senior Product Manager
Miltenyi Biotec
Lotta Räty
Miltenyi Biotec
Mrs Joanne Sharpe
Key Account Manager
Miltenyi Biotec Ltd
Mr Robin Stamm
Product Manager
Miltenyi Biotec
Germany